(Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson’s COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
(Reporting by Manojna Maddipatla in Bengaluru, Editing by Franklin Paul)
Phillies’ Spencer Turnbull has no-hit bid through 6 innings vs. White Sox
Collin Morikawa part of 4-way tie for the lead at Hilton Head. Scottie Scheffler lurks 3 shots back
Nuggets forward Michael Porter Jr. heads into playoffs against Lakers after trying week for family
Mario Andretti offended by F1 rejection. ‘If they want want blood, well, I’m ready,’ says 1978 champ
Coyotes’ move to Salt Lake City elicits opposing responses in 2 cities
USC cancels graduation keynote by filmmaker amid controversy over decision to drop student’s speech
Seeking ‘the right side of history,’ Speaker Mike Johnson risks his job to deliver aid to Ukraine
Idaho group says it is exploring a ballot initiative for abortion rights and reproductive care
Man who won primary election while charged with murder convicted on lesser charge
Thai plastics firm will pay $20 million to settle with U.S. over Iran sanctions violations
USC cancels graduation keynote by filmmaker amid controversy over decision to drop student’s speech
Taylor Swift’s ‘The Tortured Poets Department’ is here. Is it poetry? This is what experts say
Phillies’ Spencer Turnbull has no-hit bid through 6 innings vs. White Sox
Seeking ‘the right side of history,’ Speaker Mike Johnson risks his job to deliver aid to Ukraine
